1,101 Followers on Owler

Ultragenyx

is a California-based biopharmaceutical company that researches and develops novel therapies for the treatment of genetic diseases... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights

Ultragenyx

is a California-based biopharmaceutical company that researches and develops novel therapies for the treatment of genetic diseases... Read more
Ultragenyx President & CEO: Emil D. Kakkis

President & CEO

Emil D. Kakkis

CEO Approval Rating

83/100

2010

PublicIndependent CompanyNASDAQRARE

Pharmaceuticals & Biotechnology
Biotechnology
28342836 NAICS listing

Annual Revenue
$560.2M
Employees
1,310
Funding
$600.8M
Acquisitions
2

News

Conference Presentation
Feb 24, 2025
GlobeNewswire
Ultragenyx to Participate at Investor Conferences in March

Ultragenyx Competitors

1BioMarin
2Sarepta
3Abeona
4Clementia Pharmaceuticals, Inc.
5Adaptimmune
6AstraZeneca
7Kite Pharma
8Bristol-Myers Squibb
9Celgene
10Merck
Unlock 11 + competitors

Trending Companies